Barrington, Illinois Clinical Trials

A listing of Barrington, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 72 clinical trials
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

ly573144
lasmiditan
preventive medication
headache
Alexian Brothers Medical Center
 (7.2 away) Contact site
  • 130 views
  • 27 Sep, 2021
  • +243 other locations
Randomized Study in Children and Adolescents With Migraine: Acute Treatment

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.

migraine in children
acute treatment
erenumab
AMITA St. Alexius Women and Children's Hospital
 (7.2 away) Contact site
  • 0 views
  • 27 Sep, 2021
  • +109 other locations
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

To evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of adjunctive treatment in subjects with schizophrenia

olanzapine
lurasidone
asenapine
abilify
aripiprazole
Alexian Brothers Center for Psychiatric Research
 (7.2 away) Contact site
  • 254 views
  • 29 Jan, 2021
  • +151 other locations
A Study to Evaluate the Efficacy Safety and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

The purpose of this study is to evaluate the efficacy and safety of guselkumab in pediatric participants aged greater than or equal to 6 through less than 18 years with chronic plaque psoriasis.

varicella
topical agents
phototherapy
plaque psoriasis
enbrel
Arlington Dermatology
 (9.0 away) Contact site
  • 51 views
  • 14 Aug, 2021
  • +49 other locations
NICU2HOME+: Supporting Illinois Families

The purpose of this project is to provide a stepwise, methodical approach to developing and testing the ability of NICU2HOME+ to support diverse Illinois families of premature infants during and after their NICU stays in an effort to address health equity, improve parenting, and reduce costs. There are 3 objectives …

prematurity
Centra Dupage Hospital
 (7.1 away) Contact site
  • 0 views
  • 09 Jul, 2021
  • +2 other locations
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

ly573144
migraine in children
lasmiditan
acute treatment
Alexian Brothers Medical Center
 (7.2 away) Contact site
  • 139 views
  • 26 Sep, 2021
  • +243 other locations
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age

The primary objective of the study is to evaluate the effectiveness of fremanezumab as compared to placebo for the preventive treatment of chronic migraine (CM). Secondary objectives are to further demonstrate the efficacy of Fremanezumab as compared to placebo for the preventive treatment of CM, to evaluate the safety and …

daily headaches
chronic migraine
headache
recurrent headaches
fremanezumab
Teva Investigational Site 14263
 (7.2 away) Contact site
  • 0 views
  • 24 Sep, 2021
  • +69 other locations
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age

The primary objective of the study is to evaluate the effectiveness of fremanezumab as compared to placebo for the preventive treatment of episodic migraine (EM). Secondary objectives are to further demonstrate the efficacy of Fremanezumab as compared to placebo for the preventive treatment of EM, to evaluate the safety and …

daily headaches
recurrent headaches
headache
fremanezumab
episodic migraine
Teva Investigational Site 14263
 (7.2 away) Contact site
  • 51 views
  • 26 Sep, 2021
  • +69 other locations
Long-Term Study That Measures the Safety and Efficacy of BMS-986165 in Participants With Psoriasis.

The main purpose of this study is to characterize the long-term safety and efficacy of the drug BMS-986165 in patients who have been previously enrolled in an applicable Phase 3 psoriasis study.

bms-986165
Dundee Dermatology
 (8.6 away) Contact site
  • 366 views
  • 26 Jan, 2021
  • +338 other locations
A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms

Psoriasis is a chronic, systemic, inflammatory disease in which skin cells build up and develop thick, red and white scaly patches on the skin. There is an unmet medical need for effective treatment in pediatric patients and this study is being done to evaluate risankizumab in pediatric participants with moderate …

systemic therapy
plaque psoriasis
ustekinumab
risankizumab
inflammatory disease
Arlington Dermatology /ID# 217472
 (9.0 away) Contact site
  • 17 views
  • 23 Sep, 2021
  • +71 other locations